July 7, 2020 / 12:37 PM / a month ago

BRIEF-Aldeyra Therapeutics Announces New Drug Application Development Plans For Dry Eye Disease

July 7 (Reuters) - Aldeyra Therapeutics Inc:

* ALDEYRA THERAPEUTICS ANNOUNCES NEW DRUG APPLICATION (NDA) DEVELOPMENT PLANS FOR DRY EYE DISEASE

* ALDEYRA THERAPEUTICS INC - TOP-LINE RESULTS FROM FIRST OF TWO PLANNED CLINICAL TRIALS BASED ON TEAR RASP LEVELS EXPECTED BY END OF 2020

* ALDEYRA THERAPEUTICS INC - NEW DRUG APPLICATION SUBMISSION FOR REPROXALAP IN DRY EYE DISEASE EXPECTED BY END OF 2021

* ALDEYRA THERAPEUTICS INC - BASED ON CURRENT OPERATING PLANS, CURRENT CASH EXPECTED TO SUPPORT OPERATIONS INTO 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below